ARTICLE
|
doi:10.20944/preprints201909.0204.v1
Subject:
Public Health And Healthcare,
Health Policy And Services
Keywords:
Office of Innovation; novel drugs; novel therapies; regulatory science; Latin American Regulatory landscape
Online: 18 September 2019 (12:51:16 CEST)